blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3186375

EP3186375 - NOVEL CAS9 PROTEINS AND GUIDING FEATURES FOR DNA TARGETING AND GENOME EDITING [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.02.2020
Database last updated on 02.09.2024
FormerRequest for examination was made
Status updated on  02.06.2017
FormerThe international publication has been made
Status updated on  28.03.2017
Most recent event   Tooltip07.02.2020Application deemed to be withdrawnpublished on 11.03.2020  [2020/11]
Applicant(s)For all designated states
North Carolina State University
1021 Main Campus Drive, 2nd Floor
Raleigh NC 27606 / US
[2017/27]
Inventor(s)01 / BARRANGOU, Rodolphe
North Carolina State University
College of Agriculture and Life Sciences
Raleigh, North Carolina 27695 / US
02 / BRINER, Alexandra E.
North Carolina State University
College of Agriculture and Life Sciences
Raleigh, North Carolina 27695 / US
 [2017/27]
Representative(s)HGF
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2017/27]Letzelter, Felix Phillip
Meissner Bolte Patentanwälte
Rechtsanwälte Partnerschaft mbB
Postfach 86 06 24
81633 München / DE
Application number, filing date15836709.427.08.2015
[2017/27]
WO2015US47136
Priority number, dateUS201462043204P28.08.2014         Original published format: US 201462043204 P
US201462043882P29.08.2014         Original published format: US 201462043882 P
[2017/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016033298
Date:03.03.2016
Language:EN
[2016/09]
Type: A1 Application with search report 
No.:EP3186375
Date:05.07.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 03.03.2016 takes the place of the publication of the European patent application.
[2017/27]
Search report(s)International search report - published on:RU03.03.2016
(Supplementary) European search report - dispatched on:EP11.02.2019
ClassificationIPC:C12N9/22, C12N9/96, C12N15/11, C12N15/113
[2018/49]
CPC:
C12N9/22 (EP,US); C12N15/8509 (US); C12N15/102 (US);
C12N15/63 (US); C12N15/79 (US); C12N15/8213 (US);
C12N15/86 (US); C12N15/907 (US); C12N9/96 (EP,US);
A01K2217/052 (US); C12N15/111 (EP,US); C12N2310/10 (EP,US);
C12N2310/20 (EP,US); C12N2800/22 (US) (-)
Former IPC [2017/27]C12N15/10, C12N15/113
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/27]
TitleGerman:NEUARTIGE CAS9-PROTEINE UND FÜHRUNGSMERKMALE FÜR DNA-TARGETING UND GENOMEDITIERUNG[2017/27]
English:NOVEL CAS9 PROTEINS AND GUIDING FEATURES FOR DNA TARGETING AND GENOME EDITING[2017/27]
French:NOUVELLES PROTÉINES CAS9 ET ÉLÉMENTS DE GUIDAGE POUR LE CIBLAGE DE L'ADN ET L'ÉDITION DU GÉNOME[2017/27]
Entry into regional phase28.03.2017National basic fee paid 
28.03.2017Search fee paid 
28.03.2017Designation fee(s) paid 
28.03.2017Examination fee paid 
Examination procedure28.03.2017Amendment by applicant (claims and/or description)
28.03.2017Examination requested  [2017/27]
28.03.2017Date on which the examining division has become responsible
11.09.2019Application deemed to be withdrawn, date of legal effect  [2020/11]
28.10.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2020/11]
Divisional application(s)EP19196063.2  / EP3633032
Fees paidRenewal fee
30.08.2017Renewal fee patent year 03
27.08.2018Renewal fee patent year 04
27.08.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2013176772  (UNIV CALIFORNIA [US], et al) [Y] 1-4 * examples 1-7 * * claims 1-155 ** figures 5-9 *;
 [XYI]  - "CRISPR-associated protein, Csn1 family [Bifidobacterium bombi DSM 19703].", GenBank, NCBI, U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD, 20894, USA, (20140805), Database accession no. KFF31259, URL: NCBI, XP002785852 [X] 5,7 * abstract * [Y] 1-4 [I] 6,8-15
    [ ] - Christian Milani ET AL, "ABSTRACT", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, US, (20140801), vol. 80, no. 20, doi:10.1128/AEM.02308-14, ISSN 0099-2240, pages 6290 - 6302, XP055517185 [ ] * table 1 * * page 6291, column r, paragraphs 2,3 *

DOI:   http://dx.doi.org/10.1128/AEM.02308-14
International search[XA]WO2013141680  (UNIV VILNIUS [LT]) [X] 19, 20, 23, 29-31 * , abstract, claims * [A] 1-4, 6-18, 21-22, 24- 27;
 [A]  - TAUTVYDAS KARVELIS et al., "crRNA and tracrRNK guide Cas9-mediated DNA interference in Streptococcus thermophilus.", RNA Biology, (20130000), vol. 10, no. Issue 5, doi:doi:10.4161/rna.24203, pages 841 - 851, XP055202455 [A] 1-4, 6-27, 29-31

DOI:   http://dx.doi.org/10.4161/rna.24203
 [A]  - KARVELIS TAUTVYDAS et al., "Programmable DNA cleavage in vitro by Cas9.", Biochem. Soc.Trans., (20130000), vol. 41, doi:doi:10.1042/BST20130164, pages 1401 - 1406, XP002735715 [A] 1-4, 6-27, 29-31

DOI:   http://dx.doi.org/10.1042/BST20130164
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.